← 產業報告目錄
Digital Biomarkers Market Size, Share & Trends Analysis Report By Applications (Sleep and Movement Disorders, Cardiovascular, Psychiatric Disorders (Mood and Behavior), Chronic Pain, Neurodegenerative Diseases, Diabetes, Respiratory Diseases, Others), By System Components, By Type, by End-User, Region And Segment Forecasts, 2023-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-25頁數 180報告編號 INSIGHTACE-2b3a601341
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
A CAGR of 23.52% is forecasted for the global Digital Biomarkers Market over the assessment period of 2023 through 2031.
The Digital Biomarkers sector involves nothing, but the data measured through specific devices to help researchers and doctors track healthy processes, diagnose diseases and other health conditions, monitor responses. This domain has witnessed marked transformation owing to technological breakthroughs and shifting healthcare dynamics.
Several factors contribute to this trajectory, including heightened need next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Digital Biomarkers Market Snapshot
Chapter 4. Global Digital Biomarkers Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Application Estimates & Trend Analysis
5.1. By Application & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Application:
5.2.1. Sleep and Movement Disorders
5.2.2. Cardiovascular
5.2.3. Psychiatric Disorders (Mood and Behavior)
5.2.4. Chronic Pain
5.2.5. Neurodegenerative Diseases
5.2.6. Diabetes
5.2.7. Respiratory Diseases
5.2.8. Others
Chapter 6. Market Segmentation 2: By System Components Estimates & Trend Analysis
6.1. By Application & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By System Components:
6.2.1. Data Collection Tools
6.2.2. Wearables Devices
6.2.3. Implantables
6.2.4. Mobile Applications
6.2.5. Data Integration Software
Chapter 7. Market Segmentation 3: By Type Estimates & Trend Analysis
7.1. By Application & Market Share, 2019-2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Type:
7.2.1. Clinical trials
7.2.2. Clinical settings
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By Application & Market Share, 2019-2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By End User:
8.2.1. Biopharmaceutical Companies
8.2.2. Payers
8.2.3. Providers
Chapter 9. Digital Biomarkers Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Digital Biomarkers Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
9.1.2. North America Digital Biomarkers Market revenue (US$ Million) estimates and forecasts By System Components, 2023-2031
9.1.3. North America Digital Biomarkers Market revenue (US$ Million) estimates and forecasts By Type, 2023-2031
9.1.4. North America Digital Biomarkers Market revenue (US$ Million) estimates and forecasts By, End User, 2023-2031
9.1.5. North America Digital Biomarkers Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
9.1.5.1. U.S.
9.1.5.2. Canada
9.2. Europe
9.2.1. Europe Digital Biomarkers Market revenue (US$ Million) By Application, 2023-2031
9.2.2. Europe Digital Biomarkers Market revenue (US$ Million) estimates and forecasts By System Components, 2023-2031
9.2.3. Europe Digital Biomarkers Market revenue (US$ Million) estimates and forecasts By Type, 2023-2031
9.2.4. Europe Digital Biomarkers Market revenue (US$ Million) estimates and forecasts By End User,2023-2031
9.2.5. Europe Digital Biomarkers Market revenue (US$ Million) by country, 2023-2031
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific Digital Biomarkers Market revenue (US$ Million) By Application, 2023-2031
9.3.2. Asia Pacific Digital Biomarkers Market revenue (US$ Million) estimates and forecasts By System Components, 2023-2031
9.3.3. Asia Pacific Digital Biomarkers Market revenue (US$ Million) estimates and forecasts By Type, 2023-2031
9.3.4. Asia Pacific Digital Biomarkers Market revenue (US$ Million) estimates and forecasts By End User, 2023-20
9.3.5. Asia Pacific Digital Biomarkers Market revenue (US$ Million) by country, 2023-2031
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America Digital Biomarkers Market revenue (US$ Million) By Application, 2023-2031
9.4.2. Latin America Digital Biomarkers Market revenue (US$ Million) estimates and forecasts By System Components, 2023-2031
9.4.3. Latin America Digital Biomarkers Market revenue (US$ Million) estimates and forecasts By Type, 2023-2031
9.4.4. Latin America Digital Biomarkers Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031
9.4.5. Latin America Digital Biomarkers Market revenue (US$ Million) by country, (US$ Million) 2023-2031
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. Middle East & Africa
9.5.1. Middle East & Africa Digital Biomarkers Market revenue (US$ Million) By Application, (US$ Million)
9.5.2. Middle East & Africa Digital Biomarkers Market revenue (US$ Million) estimates and forecasts By System Components, 2023-2031
9.5.3. Middle East & Africa Digital Biomarkers Market revenue (US$ Million) estimates and forecasts By Type, 2023-2031
9.5.4. Middle East & Africa Digital Biomarkers Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031
9.5.5. Middle East & Africa Digital Biomarkers Market revenue (US$ Million) by country, (US$ Million) 2023-2031
9.5.5.1. South Africa
9.5.5.2. GCC Countries
9.5.5.3. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. AliveCor Inc.
10.2.2. Akili Interactive Labs, Inc.
10.2.3. Cambridge Cognition Ltd
10.2.4. Dassault Systèmes
10.2.5. IXICO plc
10.2.6. Koninklijke Philips N.V
10.2.7. Shimmer
10.2.8. Quanterix Corporation
10.2.9. Altoida AG
10.2.10. Evidation Health, Inc.
10.2.11. Happify, Inc.
10.2.12. Huma
10.2.13. Human API
10.2.14. Mindstrong Health
10.2.15. Neurotrack Technologies,
10.2.16. Orikami
10.2.17. Winterlight Labs Inc.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們